Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis
Purpose The benefit of adjuvant therapy (AT) for biliary tract cancer (BTC) is unclear, with
conflicting results from nonrandomized studies. We report a systematic review and meta …
conflicting results from nonrandomized studies. We report a systematic review and meta …
Cholangiocarcinoma
Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to
diagnose, and is associated with a high mortality. The incidence of intrahepatic …
diagnose, and is associated with a high mortality. The incidence of intrahepatic …
Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition
M Nagino, S Hirano, H Yoshitomi, T Aoki… - Journal of Hepato …, 2021 - Wiley Online Library
Abstract Background The Japanese Society of Hepato‐Biliary‐Pancreatic Surgery launched
the clinical practice guidelines for the management of biliary tract cancers …
the clinical practice guidelines for the management of biliary tract cancers …
[HTML][HTML] Intrahepatic cholangiocarcinoma: expert consensus statement
Abstract An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus
meeting of expert panellists met on 15 January 2014 to review current evidence on the …
meeting of expert panellists met on 15 January 2014 to review current evidence on the …
[HTML][HTML] Hilar cholangiocarcinoma: expert consensus statement
Abstract An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus
meeting of expert panellists met on 15 January 2014 to review current evidence on the …
meeting of expert panellists met on 15 January 2014 to review current evidence on the …
SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic …
Purpose The role of postoperative therapy in extrahepatic cholangiocarcinoma (EHCC) or
gallbladder carcinoma (GBCA) is unknown. S0809 was designed to estimate 2-year survival …
gallbladder carcinoma (GBCA) is unknown. S0809 was designed to estimate 2-year survival …
Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors
A Nakeeb, HA Pitt, TA Sohn, JA Coleman… - Annals of …, 1996 - journals.lww.com
Objective The objective of this article is to introduce a simple method for classifying
cholangiocarcinomas and to apply this system to analyze a large number of patients from a …
cholangiocarcinomas and to apply this system to analyze a large number of patients from a …
Biliary tract cancers
In the United States, an estimated 20,000 new cases of liver and biliary tract cancer are
diagnosed annually. 1 Biliary tract cancer is the second most common primary hepatobiliary …
diagnosed annually. 1 Biliary tract cancer is the second most common primary hepatobiliary …
[PDF][PDF] Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment
B Blechacz, GJ Gores - Hepatology, 2008 - Wiley Online Library
Cholangiocarcinoma (CCA) is an epithelial can-cer originating from the bile ducts with
features of cholangiocyte differentiation. 1 CCA is the second most common primary hepatic …
features of cholangiocyte differentiation. 1 CCA is the second most common primary hepatic …
Pyogenic hepatic abscess: changing trends over 42 years
CJ Huang, HA Pitt, PA Lipsett, FA Osterman Jr… - Annals of …, 1996 - journals.lww.com
Pyogenic Hepatic Abscess: Changing Trends Over 42 Years : Annals of Surgery Pyogenic
Hepatic Abscess: Changing Trends Over 42 Years : Annals of Surgery Annals of Surgery …
Hepatic Abscess: Changing Trends Over 42 Years : Annals of Surgery Annals of Surgery …